InvestorsHub Logo

bigarena

01/08/19 9:07 AM

#2277 RE: e-ore #2276

Still here and sitting tight.....holding.This time 3yrs ago it was near or at 40 cents

greasemonkeyshoes

01/08/19 10:03 AM

#2278 RE: e-ore #2276

Good eye.............
Same article,the part that I like
"Central line associated bloodstream infections (CLABSIs) have been a central focus of CDC and other infection control organizations for years. Now the eighth leading cause of death in the USA, an estimated 41,000 CLABSIs occurred in 2009 with an attributable mortality of 14-40%. Of equal concern are arterial lines, which have been shown in multiple studies to have nearly the same infection rates as central lines.

Findings from the present study have encouraged Access Scientific to expand its BioGUARD technology application from midlines to extended-dwell catheters, central venous access devices and arterial lines. The Arterial WAND™ is expected to launch in the first quarter 2019, with ChronoFlex C central lines scheduled to follow soon thereafter. The POWERWAND EDC (3Fr, 6cm. Extended-Dwell Catheter) was launched in 2017 as the first-ever truly extended dwell catheter and is rapidly setting a new standard of care throughout the country."

ps-the pipe line just keep on growing.Wooowwww.

bigarena

02/14/19 7:34 PM

#2310 RE: e-ore #2276

E-ore you checked this out?